Immunity against the Wuhan coronavirus from the vaccine and previous infections both lasts six months, according to a brief released by the Centers for Disease Control and Prevention (CDC) on Friday.
In the brief, the agency said that current data shows that individuals who are fully vaccinated and those who had a previous COVID-19 infection each have a low risk of contracting another COVID infection for six months.
“Available evidence shows that fully vaccinated individuals and those previously infected with SARS-CoV-2 each have a low risk of subsequent infection for at least 6 months,” the brief reads. “Data are presently insufficient to determine an antibody titer threshold that indicates when an individual is protected from infection. At this time, there is no FDA-authorized or approved test that providers or the public can use to reliably determine whether a person is protected from infection.”
The brief also claims that evidence indicates that “vaccination after infection significantly enhances protection and further reduces risk of reinfection.” The CDC currently recommends the COVID-19 vaccination for all eligible persons, including those who’ve previously had the virus.
“[T]here is a wide range in antibody titers in response to infection with SARS-CoV-2, completion of a primary vaccine series, especially with mRNA vaccines, typically leads to a more consistent, and higher-titer initial antibody response,” the brief reads. “[A]ntibody test results (particularly when not standardized nor quantitative) provide only a partial picture of an individual’s immune response. At this time there is no specific antibody test or antibody threshold that can determine an individual’s risk of subsequent infection.”
Recommended
A separate study released by the CDC on Friday showed that the COVID-19 vaccine provides better protection against hospitalization than a previous infection with the virus.
“We now have additional evidence that reaffirms the importance of COVID-19 vaccines, even if you have had prior infection,” CDC Director Rochelle Walensky said in a statement on the study. “This study adds more to the body of knowledge demonstrating the protection of vaccines against severe disease from COVID-19.”
Join the conversation as a VIP Member